141 related articles for article (PubMed ID: 14760072)
21. The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.
Richard E; Arredondo-Vega FX; Santisteban I; Kelly SJ; Patel DD; Hershfield MS
J Exp Med; 2000 Nov; 192(9):1223-36. PubMed ID: 11067872
[TBL] [Abstract][Full Text] [Related]
22. Antileukemic efficacy of 2-deoxycoformycin in monocytic leukemia cells.
Niitsu N; Yamamoto-Yamaguchi Y; Kasukabe T; Okabe-Kado J; Umeda M; Honma Y
Blood; 2000 Aug; 96(4):1512-6. PubMed ID: 10942399
[TBL] [Abstract][Full Text] [Related]
23. Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.
Spiers AS
Haematologia (Budap); 1996; 27(2):55-84. PubMed ID: 14651224
[TBL] [Abstract][Full Text] [Related]
24. Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26.
Eltzschig HK; Faigle M; Knapp S; Karhausen J; Ibla J; Rosenberger P; Odegard KC; Laussen PC; Thompson LF; Colgan SP
Blood; 2006 Sep; 108(5):1602-10. PubMed ID: 16670267
[TBL] [Abstract][Full Text] [Related]
25. Comparative effects of cladribine, fludarabine and pentostatin on nucleotide metabolism in T- and B-cell lines.
Wilson PK; Szabados E; Mulligan SP; Christopherson RI
Int J Biochem Cell Biol; 1998 Jul; 30(7):833-42. PubMed ID: 9722988
[TBL] [Abstract][Full Text] [Related]
26. Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule.
Martín M; Huguet J; Centelles JJ; Franco R
J Immunol; 1995 Nov; 155(10):4630-43. PubMed ID: 7594462
[TBL] [Abstract][Full Text] [Related]
27. Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma.
Mizokami Y; Kajiyama H; Shibata K; Ino K; Kikkawa F; Mizutani S
Int J Cancer; 2004 Jul; 110(5):652-9. PubMed ID: 15146553
[TBL] [Abstract][Full Text] [Related]
28. Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxin.
Montgomery RB; Kurtzberg J; Rhinehardt-Clark A; Haleen A; Ramakrishnan S; Olsen GA; Peters WP; Smith CA; Haynes BF; Houston LL
Bone Marrow Transplant; 1990 Jun; 5(6):395-402. PubMed ID: 2369680
[TBL] [Abstract][Full Text] [Related]
29. 2'-Deoxycoformycin inhibition of adenosine deaminase in rat brain: in vivo and in vitro analysis of specificity, potency, and enzyme recovery.
Padua R; Geiger JD; Dambock S; Nagy JI
J Neurochem; 1990 Apr; 54(4):1169-78. PubMed ID: 2179470
[TBL] [Abstract][Full Text] [Related]
30. Regulation of p38 phosphorylation and topoisomerase IIalpha expression in the B-cell lymphoma line Jiyoye by CD26/dipeptidyl peptidase IV is associated with enhanced in vitro and in vivo sensitivity to doxorubicin.
Yamochi T; Yamochi T; Aytac U; Sato T; Sato K; Ohnuma K; McKee KS; Morimoto C; Dang NH
Cancer Res; 2005 Mar; 65(5):1973-83. PubMed ID: 15753397
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells.
Grabarczyk P; Przybylski GK; Depke M; Völker U; Bahr J; Assmus K; Bröker BM; Walther R; Schmidt CA
Oncogene; 2007 May; 26(26):3797-810. PubMed ID: 17173069
[TBL] [Abstract][Full Text] [Related]
33. Differential sensitivity of leukemic cells to growth inhibition by deoxyadenosine and deoxycoformycin.
Tanaka M; Kimura K
Tohoku J Exp Med; 1985 Dec; 147(4):331-41. PubMed ID: 3879563
[TBL] [Abstract][Full Text] [Related]
34. Induction of apoptosis in vivo and in vitro in hairy cell leukemia treated by deoxycoformycin.
Ogawa K; Shichishima T; Nakamura N; Maruyama Y
Tohoku J Exp Med; 2000 Sep; 192(1):87-98. PubMed ID: 11128872
[TBL] [Abstract][Full Text] [Related]
35. Identification of a panel of ten cell surface protein antigens associated with immunotargeting of leukemias and lymphomas by peripheral blood gammadelta T cells.
Gomes AQ; Correia DV; Grosso AR; Lança T; Ferreira C; Lacerda JF; Barata JT; Silva MG; Silva-Santos B
Haematologica; 2010 Aug; 95(8):1397-404. PubMed ID: 20220060
[TBL] [Abstract][Full Text] [Related]
36. The structure and function of CD26 in the T-cell immune response.
Morimoto C; Schlossman SF
Immunol Rev; 1998 Feb; 161():55-70. PubMed ID: 9553764
[TBL] [Abstract][Full Text] [Related]
37. Biochemical correlates of the differential sensitivity of subtypes of human leukemia to deoxyadenosine and deoxycoformycin.
Matsumoto SS; Yu AL; Bleeker LC; Bakay B; Kung FH; Nyhan WL
Blood; 1982 Nov; 60(5):1096-102. PubMed ID: 6289941
[TBL] [Abstract][Full Text] [Related]
38. Reinforcement of antitumor effect of Cordyceps sinensis by 2'-deoxycoformycin, an adenosine deaminase inhibitor.
Yoshikawa N; Nakamura K; Yamaguchi Y; Kagota S; Shinozuka K; Kunitomo M
In Vivo; 2007; 21(2):291-5. PubMed ID: 17436579
[TBL] [Abstract][Full Text] [Related]
39. CD9 negatively regulates CD26 expression and inhibits CD26-mediated enhancement of invasive potential of malignant mesothelioma cells.
Okamoto T; Iwata S; Yamazaki H; Hatano R; Komiya E; Dang NH; Ohnuma K; Morimoto C
PLoS One; 2014; 9(1):e86671. PubMed ID: 24466195
[TBL] [Abstract][Full Text] [Related]
40. Increase in 2',5'-oligoadenylate synthetase caused by deoxycoformycin in hairy cell leukaemia.
Ganeshaguru K; de Mel WC; Sissolak G; Catovsky D; Dearden CE; Mehta AB; Hoffbrand AV
Br J Haematol; 1992 Feb; 80(2):194-8. PubMed ID: 1550776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]